Melanoma trials in Singapore

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  Where

  Singapore

  Age

  18 years and over

  People

  340 worldwide

  Run by

  Inhibrx Biosciences, Inc

  See details and how to joinNCT04198766
• Phase 3Taking people
  Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

  Where

  Singapore

  Age

  18 years to 70 years

  People

  670 worldwide

  Run by

  Iovance Biotherapeutics, Inc.

  See details and how to joinNCT05727904 · EU 2022-503140-41-00
• No phaseTaking people
  Using QPOP to Predict Treatment for Sarcomas and Melanomas

  Where

  Singapore

  Age

  21 years to 99 years

  People

  100

  Run by

  National Cancer Centre, Singapore

  See details and how to joinNCT04986748